Awards & Recognition
★Serves on Board of Directors of Albert and Mary Lasker Foundation
★Harvard BA and Harvard Medical School MD graduate
Notable Facts
→Founder and CEO of NASDAQ-listed Vera Therapeutics (VERA) since 2016
→Previously founded and led Trucode Gene Repair as CEO
→Former Senior Director at Gilead Sciences, contributed to 7 new drug approvals including TAF/GENVOYA program
→Entrepreneur in residence at prestigious VC firm Kleiner Perkins
→Harvard Medical School graduate with infectious disease specialty training from Columbia
→Chief Resident at NYU Bellevue and research fellow at Rockefeller University
→Led company through IPO in 2021, raised over $1 billion in capital
→Company's lead drug atacicept advancing through Phase 3 trials for autoimmune diseases
→Advisor to Google X and multiple biotech companies